The interface between diabetic retinopathy, diabetes management, and insulin-like growth factors.

[1]  S. Lamberts,et al.  Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.

[2]  Lois E. H. Smith,et al.  Essential role of growth hormone in ischemia-induced retinal neovascularization. , 1997, Science.

[3]  A. D'ercole.  Insulin-like growth factors and their receptors in growth. , 1996, Endocrinology and metabolism clinics of North America.

[4]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[5]  R. Baserga,et al.  Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. , 1993, Cancer research.

[6]  P. Porcu,et al.  Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. , 1992, Cancer research.

[7]  R. Natarajan,et al.  Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. , 1992, Biochemical and biophysical research communications.

[8]  M. Snyder,et al.  Glucose induces cAMP-independent growth-related changes in stationary-phase cells of Saccharomyces cerevisiae. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Merimee,et al.  Diabetic retinopathy. A synthesis of perspectives. , 1990, The New England journal of medicine.

[10]  G. King,et al.  Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Loskutoff,et al.  Plasminogen activator inhibitor-type I is a major biosynthetic product of retinal microvascular endothelial cells and pericytes in culture. , 1989, The Biochemical journal.

[12]  M. Grant,et al.  Insulin-Like Growth Factors in Vitreous: Studies in Control and Diabetic Subjects with Neovascularization , 1986, Diabetes.

[13]  T. Merimee.  A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. , 1978, The New England journal of medicine.

[14]  E. Kohner,et al.  Florid Diabetic Retinopathy and its Response to Treatment by Photocoagulation or Pituitary Ablation , 1976, Diabetes.

[15]  J. E. Poulsen.  The Houssay Phenomenon in Man: Recovery from Retinopathy in a Case of Diabetes With Simmonds' Disease , 1953, Diabetes.